The latest closing stock price for Zevra Therapeutics as of June 17, 2025 is 8.81.
An investor who bought $1,000 worth of Zevra Therapeutics stock at the IPO in 2015 would have $-951 today, roughly -1 times their original investment - a -26.01% compound annual growth rate over 10 years.
The all-time high Zevra Therapeutics stock closing price was 378.08 on September 18, 2015.
The Zevra Therapeutics 52-week high stock price is 9.76, which is 10.8% above the current share price.
The Zevra Therapeutics 52-week low stock price is 4.20, which is 52.3% below the current share price.
The average Zevra Therapeutics stock price for the last 52 weeks is 7.71.
An investor who bought $1,000 worth of Zevra Therapeutics stock at the IPO in 2015 would have $-951 today, roughly -1 times their original investment - a -26.01% compound annual growth rate over 10 years.
The all-time high Zevra Therapeutics stock closing price was 378.08 on September 18, 2015.
The Zevra Therapeutics 52-week high stock price is 9.76, which is 10.8% above the current share price.
The Zevra Therapeutics 52-week low stock price is 4.20, which is 52.3% below the current share price.
The average Zevra Therapeutics stock price for the last 52 weeks is 7.71.